GCIA
SGFY

Gabelli & Co Investment Advisers’s Signify Health, Inc. SGFY Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-327,350
Closed -$9.38M – 277
2022
Q4 		$9.38M Buy
327,350
+154,750
+90% +$4.47M 2% 16
2022
Q3 		$5.03M Buy
+172,600
New +$3.98M 0.65% 38

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Gabelli & Co Investment Advisers's SGFY Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 327,350 shares — an estimated $9.38M sold.

Gabelli & Co Investment Advisers first reported a position in SGFY in Q3 2022 and held it in 2 quarters. The position peaked at $9.38M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 327,350 Signify Health, Inc. shares in Q1 2023, an estimated $9.38M.
  • Gabelli & Co Investment Advisers first reported a position in Signify Health, Inc. in Q3 2022 and held it in 2 quarters.
  • Gabelli & Co Investment Advisers's Signify Health, Inc. position peaked at $9.38M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.